指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

COVID-19大流行期间肝病学与肝移植提供者的临床最佳实践建议:AASLD专家小组共识声明

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
指南 / 共识 · Hepatology · 2020-01-01
一句话结论AASLD专家小组发布COVID-19大流行期间肝病与肝移植临床实践建议,强调形势快速演变、建议将持续更新。

本文为AASLD专家小组共识声明,旨在提供COVID-19已知信息及其对肝病学家、肝移植提供者、肝病患者和肝移植受者影响的指导。文章讨论了COVID-19对肝病相关人群的影响,并为临床医生提供如何最小化大流行对患者护理影响的指导。声明指出形势正在快速演变,建议也需要随之更新,将根据对COVID-19影响肝病患者护理的新认识更新在线文档。

要点

  • 本文为AASLD专家小组共识声明,提供COVID-19大流行期间肝病学与肝移植临床实践建议。
  • 目标人群为肝病学家、肝移植提供者、肝病患者和肝移植受者。
  • 声明指出形势正在快速演变,建议也需要随之更新。
  • 将根据对COVID-19影响肝病患者护理的新认识更新在线文档。

适用人群与场景

  • 肝病学家、肝移植提供者、肝病患者和肝移植受者。

研究设计与关键结果

  • 制定机构:AASLD专家小组;方法:专家小组共识声明。
  • 文章讨论了COVID-19已知信息,聚焦其对肝病学家、肝移植提供者、肝病患者和肝移植受者的影响。
  • 文章为临床医生提供如何最小化COVID-19大流行对患者护理影响的指导。

证据类型、等级与局限

  • 证据类型:专家小组共识声明。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 声明指出形势正在快速演变,建议也需要随之更新。
  • 将根据对COVID-19大流行影响肝病患者护理的新认识更新在线文档。

指南或共识出处

  • AASLD专家小组共识声明:COVID-19大流行期间肝病学与肝移植提供者的临床最佳实践建议。
  • 在线文档:https://www.aasld.org/about-aasld/covid-19-and-liver。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND AIMS: Coronavirus disease 2019 (COVID-19), the illness caused by the SARS-CoV-2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients, but few are wholly equipped to manage this new disease. The goals of this document are to provide data on what is currently known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and healthcare providers.

APPROACH AND RESULTS: This article discusses what is known about COVID-19 with a focus on its impact on hepatologists, liver transplant providers, patients with liver disease, and liver transplant recipients. We provide clinicians with guidance for how to minimize the impact of the COVID-19 pandemic on their patients' care.

CONCLUSIONS: The situation is evolving rapidly, and these recommendations will need to evolve as well. As we learn more about how the COVID-19 pandemic impacts the care of patients with liver disease, we will update the online document available at https://www.aasld.org/about-aasld/covid-19-and-liver.

来源:Hepatology,查看原文。版权归原作者所有。

参考来源

  1. Fix OK, Hameed B, Fontana RJ, et al. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement. Hepatology. 2020. PMID: 32298473. doi:10.1002/hep.31281

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。